Cue Biopharma Inc

NASDAQ:CUE 3:59:43 PM EDT

14.39

+3.13 (+27.80%)

4:02:38 PM EDT: $14.58 +0.19 (+1.32%)

Market Cap (Intraday)	438.93M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.59 Million
Adjusted EPS	-$0.38

See more estimates

10-Day MA	$12.58
50-Day MA	$12.78
200-Day MA	$14.45

See more pivots

Cue Biopharma Inc Stock, NASDAQ:CUE

21 Erie Street, Cambridge, Massachusetts 02139

United States of America

Phone: +1.617.949.2680

Number of Employees: 50

http://www.cuebiopharma.com

Description

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and, Rodolfo Chaparro on December 31, 2014 and is headquartered in Cambridge, MA.